Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Bill would require MAT programs to offer long-acting reversible contraception; sponsor cites neonatal abstinence concerns
Summary
House Bill 2349 would require medication-assisted treatment (MAT) programs to offer long-acting reversible contraceptives or establish referral systems; sponsor said the measure aims to reduce neonatal abstinence syndrome rates and health care costs.
A Senate committee voted to report House Bill 2349 to the full Senate with a recommendation that it do pass, with a directive that the bill be first referred to the Committee on Finance under the original double committee reference. The bill would require licensed medication-assisted treatment (MAT) programs to offer long-acting reversible contraceptives (LARCs) to new and current patients or to establish a referral system if they lack a qualified provider.
Delegate Sarah German, the bill’s House sponsor, spoke to…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
